Range Cancer Therapeutics ETF
Cottonwood ETF Holdings LLC CNCR ETF
| CNCR Price | $8.9 |
Market Cap | $6.94M |
| Annual Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
| Yearly Management Fee | 0.79% |
Asset Class | Equity |
| Focus | Health care |
Category | Sector, Health Care |
| Niche | Pharma, biotech & life sciences |
Last 24h Volume | $2.13K |
| Portfolio Management Company | Cottonwood ETF Holdings LLC |
Discount/Premium to NAV | 0.34% |
| Inception Date | Oct 13, 2015 |
Market Cap Rank | 3688 |
| Monthly AUM Growth | -2.58% |
Holdings Region | Global |
| Management Style | Passive |
Leverage | Non-Leveraged |
Range Cancer Therapeutics ETF is an ETF issued by Cottonwood ETF Holdings LLC on Oct 13 2015.
The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care".
As of today, the price of CNCR ETF according to its net asset value is premiumed at 0.34%.
While the total value of the fund shows $-183,570 decrease compared to the previous month, its price is traded daily at a decrease of -0.22%.
The annual dividend yield of CNCR ETF is 0.00%, whereas its main asset area is Global.
CNCR ETF, whose 24-hour total volume is $2.13K, has experienced a $0 cash outflow in the last month.
In addition, Range Cancer Therapeutics ETF's net asset value total return is 0.00%.
CNCR ETF Returns
| Daily |
Weekly |
Monthly |
3 Mo |
6 Mo |
YTD |
Yearly |
| -0.22% |
-2.94% |
0.23% |
-29.53% |
-37.54% |
-28.51% |
-41.87% |
CNCR ETF NAV Total Return
| Monthly |
3 Mo |
YTD |
Yearly |
3 Years |
5 Years |
| -2.57% |
-29.92% |
-27.74% |
-40.93% |
-40.08% |
-61.55% |
CNCR ETF Fund Flows Chart
CNCR ETF Market Cap Chart
CNCR ETF NAV Growth Chart
CNCR ETF Comments
no comments yet